Russ Hawkinson - 08 Dec 2020 Form 4/A - Amendment Insider Report for Silverback Therapeutics, Inc. (SPRY)

Role
Sr. Vice President of Finance
Signature
/s/ Jeffrey C. Pepe, Attorney-in-Fact
Issuer symbol
SPRY
Transactions as of
08 Dec 2020
Net transactions value
+$4,200
Form type
4/A - Amendment
Filing time
24 Feb 2022, 18:55:23 UTC
Date Of Original Report
08 Dec 2020
Next filing
02 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPRY Common Stock Purchase $4,200 +200 $21.00 200 08 Dec 2020 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were purchased in the Issuer's initial public offering.
F2 On December 8, 2020, the reporting person filed a Form 4 in which he inadvertently reported a purchase of 238 shares of the issuer's common stock. In fact, as reported in this amendment, the reporting person purchased 200 shares of the issuer's common stock.